The co‐occurrence of high PTGER4 expression and 1p36 deletion suggests a potential compensatory relationship, where the loss of tumour suppressors at 1p36 may be counterbalanced by the upregulation of PTGER4‐mediated tumour‐suppressive pathways, such as immune activation. This evidence concerns the gene PTGER4 and neoplasm.